

QUICK LINKS
A selective dopamine agonist that is being considered for the parenteral treatment of systemic hypertension. In both an oral and parenteral form, this compound causes peripheral vasodilation by stimulating dopamine-1 adrenergic receptors. Intravenous fenoldopam may provide advantages over sodium nitroprusside because it can induce both a diuresis and natriuresis. It is not light sensitive, nor is it associated with cyanide toxicity. There is no evidence for rebound hypertension after discontinuation of fenoldopam infusion.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Fenoldopam monohydrobromide, 5 mg | sc-215032 | 5 mg | $175.00 | |||
Fenoldopam monohydrobromide, 25 mg | sc-215032A | 25 mg | $375.00 |